betulinic acid has been researched along with sorafenib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kutkowska, J; Rapak, A; Strzadala, L | 2 |
2 other study(ies) available for betulinic acid and sorafenib
Article | Year |
---|---|
Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.
Topics: A549 Cells; Apoptosis; Betulinic Acid; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Combined Modality Therapy; Drug Synergism; Flow Cytometry; Humans; Mutation; Niacinamide; Pentacyclic Triterpenes; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Sorafenib; Triterpenes | 2017 |
Sorafenib in Combination with Betulinic Acid Synergistically Induces Cell Cycle Arrest and Inhibits Clonogenic Activity in Pancreatic Ductal Adenocarcinoma Cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Betulinic Acid; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Synergism; Humans; Pancreatic Neoplasms; Pentacyclic Triterpenes; Sorafenib; Triterpenes; Tumor Stem Cell Assay | 2018 |